Tag: Prescription Drugs
High Response Incidence Seen for Axatilimab in Recurrent, Refractory GVHD
Primary end point was met, with overall response for 74, 67, and 50 percent receiving axatilimab 0.3 mg, 1 mg, and 3 mg per kilogram of body weight
Paternal Antiseizure Rx Use at Conception Does Not Pose Risk to Offspring
No clear evidence seen for adverse impact of paternal antiseizure medication use on offspring outcomes
In 2021, More Than 1 Million Deaths Attributed to Antimicrobial Resistance
Estimated 1.91 million deaths attributed to AMRs and 8.22 million deaths associated with AMR could occur globally by 2050
Tivozanib Has Efficacy in Advanced Renal Cell Carcinoma Post-ICI Therapy
No benefit seen for rechallenge with nivolumab after progression in the post-immune checkpoint inhibitor setting
Adjuvant Pembrolizumab Improves Survival in Muscle-Invasive Urothelial Cancer
Improved disease-free survival seen among patients with high-risk muscle-invasive urothelial carcinoma after radical surgery
Pembrolizumab + Chemo Beneficial for Early-Stage Triple-Negative Breast Cancer
Overall survival higher in group receiving pembrolizumab plus chemo versus chemotherapy alone
Adjuvant Durvalumab Extends Survival in Small Cell Lung Cancer
Significantly longer overall and progression-free survival seen among patients with limited-stage small cell lung cancer
Erenumab Effective for Nonopioid Medication Overuse Headache in Chronic Migraine
Safety profile similar to other trials, with six in 10 sustaining medication overuse headache remission over six months
Rx Amphetamine Use Linked to Increased Odds of Psychosis, Mania
Dose-response relationship seen, with increased odds for high doses of amphetamine
Rx Up for Stimulants and Antidepressants, Down for Opioids, 2019 to 2022
Proportion of telehealth prescriptions climbed across medications
